TrialDiabetes, obesity & metabolism2026

Acarbose or Canagliflozin vs. Placebo to Ameliorate Post-Bariatric Hypoglycaemia: The Clinical Outcomes of the HypoBar I Randomised Clinical Trial.

Carolina B Lobato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.